Clinical Trial Update: Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating topical ruxolitinib cream for atopic dermatitis in adolescents and adults has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Ruxolitinib Cream (ruxolitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2021-12-17